New way of regulating alternative splicing in retroviruses: The promoter makes a difference

Journal of Virology

Volumn 81, Issue 7, 2007, Pages 3652-3656

  Bohne, Jens ^a   Schambach, Axel ^a   Zychlinski, Daniela ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEOMICS; PROVIRUS; RETROVIRUS; RNA SPLICING; VIRUS GENE;

ALTERNATIVE SPLICING; CYTOMEGALOVIRUS; GENE PRODUCTS, TAT; HIV; HIV LONG TERMINAL REPEAT; LEUKEMIA VIRUS, MURINE; PROMOTER REGIONS (GENETICS); RNA, VIRAL; VIRAL ENVELOPE PROTEINS;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE;

EID: 33947403113     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02105-06     Document Type: Article

References (26)

1. Berro, R., K. Kehn, C. de la Fuente, A. Pumfery, K. Adair, J. Wade, A. M. Colberg-Poley, J. Hiscott, and F. Kashanchi. 2006. Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. J. Virol. 80:3189-32114.
2. Bohne, J., H. Wodrich, and H. G. Kransslich. 2005. Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5′ end. Nucleic Acids Res. 33:825-837.
3. Caputi, M., and A. M. Zahler. 2002. SR proteins and bnRNP H regulate the splicing of the HIV-1 1cv-specific exon 6D. EMBO J. 21:845-855.
4. Chang, L. J., E. McNulty, and M. Martin. 1993. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. J. Virol. 67:743-752.
5. Chang, L. J., and C. Zhang. 1995. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Virology 211:157-169.
6. Coffin, J. M., S. H. Hughes, and H. E. Varmus. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
7. Cook, C. R., and M. T. McNally. 1999. Interaction between the negative regulator of splicing element and a 3′ splice site: requirement for U1 small nuclear ribonucleoprotein and the 3′ splice site branch point/pyrimidine tract. J. Virol. 73:2394-2400.
8. Cramer, P., C. G. Pesce, F. E. Baralle, and A. R. Kornblihtt. 1997. Functional association between promoter structure and transcript alternative splicing. Proc. Natl. Acad. Sci. USA 94:11456-11460.
9. de la Mata, M., C. R. Alonso, S. Kadener, J. P. Fededa, M. Blaustein, F. Pelisch, P. Cramer, D. Bentley, and A. R. Kornblihtt. 2003. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell 12:525-532.
10. Domsic, J. K., Y. Wang, A. Mayeda, A. R. Krainer, and C. M. Stoltzfus. 2003. Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polvpyrimidine tracts. Mol. Cell. Biol. 23:8762-8772.
11. Erlwein, O., C. J. Buchholz, and B. S. Schnierle. 2003. The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus. J. Gen. Virol. 84:369-373.
12. Goldstrohm, A. C., A. L. Greenleaf, and M. A. Garcia-Blanco. 2001. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 277:31-47.
13. Graveley, B. R. 2001. Alternative splicing: increasing diversity in the proteomic world. Trends Genet. 17:100-107.
14. Kraunus, J., D. H. Schaumann. J. Meyer, U. Modlich, B. Fehse, G. Brandenburg, D. Von Laer, H. Klump, A. Schambach, J. Bohne, and C. Baum. 2004. Self-inactivating retroviral vectors with improved RNA processing. Gene Ther. 11:1568-1578.
15. Luo, Y., H. Yu, and B. M. Peterlin. 1994. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68:3850-3856.
16. Madsen, J. M., and C. M. Stoltzfus. 2005. An exonic splicing silencer downstream of the 3′ splice site A2 is required for efficient human immunodeficiency virus type 1 replication. J. Virol. 79:10478- 10486.
17. Marchand, V., A. Mereau, S. Jacquenet, D. Thomas, A. Mougin, R. Gattoni, J. Stevenin, and C. Branlant. 2002. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. J. Mol. Biol. 323:629-652.
18. Modrek, B., and C. Lee. 2002. A genomic view of alternative splicing. Nat. Genet. 30:13-19.
19. Ott, M., M. Schnolzer, J. Garnica, W. Fischle, S. Emiliani, H. R. Rackwitz, and E. Verdin. 1999. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 9:1489-1492.
20. Purcell, D. F., and M. A. Martin. 1993. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67:6365-6378.
21. Roberts, G. C., C. Gooding, H. Y. Mak, N. J. Proudfoot, and C. W. Smith. 1998. Co-transcriptional commitment to alternative splice site selection. Nucleic Acids Res. 26:5568-5572.
22. Robinson, D., J. F. Elliott, and L. J. Chang. 1995. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat. Gene Ther. 2:269-278.
23. Robson-Dixon, N. D., and M. A. Garcia-Blanco. 2004. MAZ elements alter transcription elongation and silencing of the fibroblast growth factor receptor 2 exon IIIb. J. Biol. Chem. 279:29075-29084.
24. Schambach, A., D. Mueller, M. Galla, M. M. Verstegen, G. Wagemaker, R. Loew, C. Baum, and J. Bohne. 2006. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther. 13:1524-1533.
25. Tange, T. O., C. K. Damgaard, S. Guth, J. Valcarcel, and J. Kjems. 2001. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 20:5748-5758.
26. Zheng, Y. H., H. F. Yu, and B. M. Peterlin. 2003. Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat. Cell Biol. 5:611-618.